177 related articles for article (PubMed ID: 7805701)
1. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
Warrington S
Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
[TBL] [Abstract][Full Text] [Related]
2. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
Warrington S; Debbas N; Farthing M; Horton M; Umile A
Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
[TBL] [Abstract][Full Text] [Related]
3. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
Reginster JY; Franchimont P
Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
[TBL] [Abstract][Full Text] [Related]
4. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.
Santucci L; Fiorucci S; Chiucchiù S; Sicilia A; Bufalino L; Morelli A
Dig Dis Sci; 1992 Dec; 37(12):1825-32. PubMed ID: 1473431
[TBL] [Abstract][Full Text] [Related]
6. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain.
Pijak MR; Turcani P; Turcaniova Z; Buran I; Gogolak I; Mihal A; Gazdik F
Bratisl Lek Listy; 2002; 103(12):467-72. PubMed ID: 12696775
[TBL] [Abstract][Full Text] [Related]
8. Renal and gastrointestinal tolerability of lornoxicam, and effects on haemostasis and hepatic microsomal oxidation.
Warrington SJ; Lewis Y; Dawnay A; Johnston A; Kovacs IB; Lamb E; Ravic M
Postgrad Med J; 1990; 66 Suppl 4():S35-40. PubMed ID: 2284219
[TBL] [Abstract][Full Text] [Related]
9. Multicentre double-blind comparison of piroxicam and indomethacin in the treatment of lumbar diseases.
Aoki T; Kuroki Y; Kageyama T; Irimajiri S; Mizushima Y; Yamamoto K
Eur J Rheumatol Inflamm; 1983; 6(3):247-52. PubMed ID: 6239779
[TBL] [Abstract][Full Text] [Related]
10. [Endoscopic, histologic and morphometric evaluation of the gastric mucosa in patients with osteoarthritis treated with piroxicam and zinc acexamate].
Guilarte López-Mañas J; Valenzuela Barranco M; Caballero Plasencia AM; Martín Ruiz JL
Gastroenterol Hepatol; 1998 May; 21(5):212-7. PubMed ID: 9644873
[TBL] [Abstract][Full Text] [Related]
11. Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain.
Chang ST; Chen LC; Chang CC; Chu HY; Tsai KC
J Clin Pharm Ther; 2008 Oct; 33(5):495-506. PubMed ID: 18834364
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain.
Dolci G; Ripari M; Pacifici L; Umile A
Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875
[TBL] [Abstract][Full Text] [Related]
13. Lornoxicam, indomethacin and placebo: comparison of effects on faecal blood loss and upper gastrointestinal endoscopic appearances in healthy men.
Warrington SJ; Debbas NM; Farthing M; Horton M; Johnston A; Thillainayagam A; Turner P; Ferber H
Postgrad Med J; 1990 Aug; 66(778):622-6. PubMed ID: 2217030
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic and endoscopic comparison of an oral and an experimental buccal piroxicam formulation.
Mueller BA; Rex DK; Figueroa N; Greene P; Brater DC
Pharmacotherapy; 1992; 12(2):93-7. PubMed ID: 1570233
[TBL] [Abstract][Full Text] [Related]
15. Rheumatic diseases--clinical experience with piroxicam-beta-cyclodextrin.
Serni U
Eur J Rheumatol Inflamm; 1993; 12(4):47-54. PubMed ID: 7805704
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers.
Thillainayagam AV; Tabaqchali S; Warrington SJ; Farthing MJ
Dig Dis Sci; 1994 May; 39(5):1085-9. PubMed ID: 8174421
[TBL] [Abstract][Full Text] [Related]
17. Macrocyclic molecules and their pharmacological applications.
Lasagna L
Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702
[No Abstract] [Full Text] [Related]
18. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
Lister RE; Acerbi D; Cadel S
Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
[TBL] [Abstract][Full Text] [Related]
19. [Comparative endoscopic study of gastroduodenal tolerance of piroxicam-beta-cyclodextrin vs piroxicam].
Müller P; Simon B
Z Rheumatol; 1997; 56(2):76-9. PubMed ID: 9235813
[TBL] [Abstract][Full Text] [Related]
20. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
Lee CR; Balfour JA
Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
